WASHINGTON, D.C. — Nov. 24, 2020 — Global law firm Greenberg Traurig, LLP has once again expanded its Health Care & FDA Practice with the addition of Andrew Tsui in the firm’s Washington, D.C. office as Of Counsel. For more than a decade, Tsui served as a litigation attorney at the U.S. Department of Health and Human Services (HHS), Office of the General Counsel, Centers for Medicare & Medicaid Services (CMS) Division. Tsui advises key stakeholders in the health care, biopharmaceutical, medical device, and pharmaceutical industries.
As former lead agency counsel, Tsui has defended CMS, HHS, Office of Medicare Hearings and Appeals, and Center for Consumer Information and Insurance Oversight rules and regulations across a wide array of national litigation. Tsui helps support the regulatory aspects of clients’ innovation and research and development, as well address and mitigate any possible future litigation actions.
“With today’s focus on innovation and the inherent costs and possible liabilities with bringing products to market, Andrew’s experience provides clients with the optics of a veteran HHS litigator. This allows him to see and plan for synergies, as well as what may be inherent conflict, between the various rules and regulations in place that affect medical devices and similar products,” said the co-chairs of Greenberg Traurig’s Health Care & FDA Practice Washington, D.C. Shareholder Nancy E . Taylor and Ft. Lauderdale Shareholder David C. Peck.
“My work as a litigator informs the strategic support and representation I offer clients not only within the traditional healthcare regulatory landscape, but also in preparation for a future that will rely on industry to help shape the next generation of coverage, coding, and payment arrangements in the us healthcare system,” Tsui said. “Greenberg Traurig’s healthcare team is uniquely positioned to advise a wide array of clients from the most veteran to new market entrants needing experienced partners to chart a clear strategy forward. All this, under one roof.”
Tsui draws on his deep experience in government litigation, policymaking, and private practice to advise and represent healthcare clients on complex matters arising under the Affordable Care Act and in the Medicare regulatory environment. His practice focuses on navigating compliance matters affecting Medicare and Medicaid reimbursement for health care delivery systems, payers, physician groups, and biopharmaceutical and medical device companies. Tsui also provides counsel on new and alternative payment models, healthcare mergers and acquisitions, and litigation.
“I look forward to capitalizing on this opportunity that Greenberg Traurig has created for clients across the globe. It is an ambitious vision, and that’s exactly the bold approach that clients expect from attorneys at a firm like GT,” Tsui said.
In addition to his service at CMS from 2008-2019, Tsui served as a Special Assistant U.S. Attorney in the U.S. District Court for the District of Columbia, a Policy Analyst at the CMS Center for Medicare & Medicaid Innovation (CMMI), 2012-2013. Most recently, Tsui was an attorney at Olsson Frank Weeda Terman Matz, PC.
Tsui received his J.D. from the University of North Carolina School of Law; his M.P.H. from the University of North Carolina Gillings School of Global Public Health; and his B.A. from Wesleyan University, with high honors. He is admitted to practice in New York. His practice is limited to federal health care practice and is not admitted in the District of Columbia.
About Greenberg Traurig’s Health Care & FDA Practice: Greenberg Traurig’s multidisciplinary Health Care & FDA Practice provides strategic counsel to a diverse group of companies and other organizations, helping them to respond proactively to the rapidly changing healthcare marketplace. The group combines dedicated experience in health care regulatory compliance and operational matters with the firm’s capabilities in corporate & securities, finance, tax, antitrust, ERISA, commercial and governmental litigation, restructuring, intellectual property and biotechnology, to provide a wide range of legal services. Learn more about Greenberg Traurig. Learn more about Greenberg Traurig’s Washington, D.C. office.